Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Dec 23

PMID 36554382

Authors

Kalpana Singh

Albara Alomari

Badriya Lenjawi

Affiliations

Soon will be listed here.

Abstract

Background: There has not been a review that evaluated the prevalence of multimorbidity in the Middle East. This review aims to measure the prevalence, demographic factors, and consequences of multimorbidity in the Middle East region.

Study Design: A quantitative systematic review includes cross-sectional and longitudinal cohort studies.

Methods: The prevalence systematic review approach from the Joanna Briggs Institute was applied. We searched PsychINFO, MEDLINE, EMCARE, CINAHL, Scopus, Science Direct, and the Cochrane Central Register of Controlled Trials. Data were extracted methodically in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards. Studies written in English and released between 2012 and March 2022 were included. For the meta-analysis, a random-effects model was applied. PROSPERO registration number: CRD42022335534.

Results: The final sample consisted of eight cohort and observational studies. The number of participants varied from 354 to 796,427. Multimorbidity was present in all populations with a prevalence of 21.8% (95% confidence interval (CI): 21.7-21.8%).

Conclusion: Multimorbidity affects a significant section of the world's population. A uniform operationalization of multimorbidity is required in the Middle East in order to enable reliable estimates of illness burden, effective disease management, and resource distribution.

Citing Articles

Demographic, health, and behaviors profile of Saudi Arabia's aging population 2022-2023.

Bindhim N, Senitan M, Almutairi M, Alhadlaq L, Alnajem S, Alfaifi M Front Aging. 2025; 6:1491146.

PMID: 40078533 PMC: 11897827. DOI: 10.3389/fragi.2025.1491146.

Multimorbidity and its associated risk factors among adults in northern Sudan: a community-based cross-sectional study.

Musa I, Hassan A, Adam I J Health Popul Nutr. 2024; 43(1):13.

PMID: 38281058 PMC: 10822146. DOI: 10.1186/s41043-024-00513-7.

Multimorbidity Patterns in the Urban Population in Poland.

Chlabicz M, Jamiolkowski J, Sowa P, Zalewska M, Kiszkiel L, Ciolkiewicz M J Clin Med. 2023; 12(18).

PMID: 37762801 PMC: 10531963. DOI: 10.3390/jcm12185860.

References

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

Noor F, Islam M . Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health. 2020; 45(6):1270-1282. PMC: 7486583. DOI: 10.1007/s10900-020-00920-x. View

Schafer I, von Leitner E, Schon G, Koller D, Hansen H, Kolonko T . Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One. 2011; 5(12):e15941. PMC: 3012106. DOI: 10.1371/journal.pone.0015941. View

Alimohammadian M, Majidi A, Yaseri M, Ahmadi B, Islami F, Derakhshan M . Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West Asia. BMJ Open. 2017; 7(5):e013548. PMC: 5623450. DOI: 10.1136/bmjopen-2016-013548. View

Fortin M, Stewart M, Poitras M, Almirall J, Maddocks H . A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012; 10(2):142-51. PMC: 3315131. DOI: 10.1370/afm.1337. View

Ryan A, Wallace E, OHara P, Smith S . Multimorbidity and functional decline in community-dwelling adults: a systematic review. Health Qual Life Outcomes. 2015; 13:168. PMC: 4606907. DOI: 10.1186/s12955-015-0355-9. View

Nunes B, Flores T, Mielke G, Thume E, Facchini L . Multimorbidity and mortality in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr. 2016; 67:130-8. DOI: 10.1016/j.archger.2016.07.008. View

Lee J, Hamid F, Pati S, Atun R, Millett C . Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis. PLoS One. 2015; 10(7):e0127199. PMC: 4496037. DOI: 10.1371/journal.pone.0127199. View

Almirall J, Fortin M . The coexistence of terms to describe the presence of multiple concurrent diseases. J Comorb. 2017; 3:4-9. PMC: 5636023. DOI: 10.15256/joc.2013.3.22. View

10.

Asogwa O, Boateng D, Marza-Florensa A, Peters S, Levitt N, van Olmen J . Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open. 2022; 12(1):e049133. PMC: 8785179. DOI: 10.1136/bmjopen-2021-049133. View

11.

Nguyen H, Manolova G, Daskalopoulou C, Vitoratou S, Prince M, Prina A . Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies. J Comorb. 2019; 9:2235042X19870934. PMC: 6710708. DOI: 10.1177/2235042X19870934. View

12.

Jang S, Kawachi I . Care inequality: care received according to gender, marital status, and socioeconomic status among Korean older adults with disability. Int J Equity Health. 2019; 18(1):105. PMC: 6610802. DOI: 10.1186/s12939-019-1008-0. View

13.

Arokiasamy P, Uttamacharya U, Jain K, Biritwum R, Yawson A, Wu F . The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?. BMC Med. 2015; 13:178. PMC: 4524360. DOI: 10.1186/s12916-015-0402-8. View

14.

Zulman D, Pal Chee C, Wagner T, Yoon J, Cohen D, Holmes T . Multimorbidity and healthcare utilisation among high-cost patients in the US Veterans Affairs Health Care System. BMJ Open. 2015; 5(4):e007771. PMC: 4401870. DOI: 10.1136/bmjopen-2015-007771. View

15.

Carter P, Lagan J, Fortune C, Bhatt D, Vestbo J, Niven R . Association of Cardiovascular Disease With Respiratory Disease. J Am Coll Cardiol. 2019; 73(17):2166-2177. DOI: 10.1016/j.jacc.2018.11.063. View

16.

Basto-Abreu A, Barrientos-Gutierrez T, Wade A, Oliveira de Melo D, Semeao de Souza A, Nunes B . Multimorbidity matters in low and middle-income countries. J Multimorb Comorb. 2022; 12:26335565221106074. PMC: 9208045. DOI: 10.1177/26335565221106074. View

17.

Ahmadi B, Alimohammadian M, Yaseri M, Majidi A, Boreiri M, Islami F . Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis. Medicine (Baltimore). 2016; 95(7):e2756. PMC: 4998618. DOI: 10.1097/MD.0000000000002756. View

18.

Ahmadi A, Shirani M, Khaledifar A, Hashemzadeh M, Solati K, Kheiri S . Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study. BMC Public Health. 2021; 21(1):2275. PMC: 8670056. DOI: 10.1186/s12889-021-12326-y. View

19.

Navickas R, Petric V, Feigl A, Seychell M . Multimorbidity: What do we know? What should we do?. J Comorb. 2017; 6(1):4-11. PMC: 5556462. DOI: 10.15256/joc.2016.6.72. View

20.

Salisbury C, Johnson L, Purdy S, Valderas J, Montgomery A . Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011; 61(582):e12-21. PMC: 3020068. DOI: 10.3399/bjgp11X548929. View